Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.

Cancer immunology, immunotherapy : CII - 1 Jan 1990

Pawelec G, Ehninger G, Schmidt H, Müller C, Bühring H J, Reutter M, Busch F W

Abstract excerpt

Chronic myelogenous leukemia (CML) patients in chronic phase display compromised lymphokine-activated killer (LAK) cell induction, which is partly restored after therapy with interferon alpha. However, the relative resistance of the leukemic cells from these patients to autologous or allogeneic LAK lysis is not affected by this treatment. In an attempt to render CML cells more susceptible to lysis or cytostasis,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to Cell Division

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Survival

Share to Cytokines

Share to Cytotoxicity, Immunologic

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 2289210
DOI: 10.1007/BF01771452
PMCID: PMC11038405

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.PMID 2289210Read ↗

[Cytolytic activity by lymphokines (LAK activity) in chronic myeloid leukemia].Semantic proximity Read ↗

Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia.Semantic proximity Read ↗

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.Semantic proximity Read ↗

Cytokine modulation of the susceptibility of acute T-lymphoblastic leukemia cell lines to LAK activity.Semantic proximity Read ↗

Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.Semantic proximity Read ↗

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.Semantic proximity Read ↗

Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.Semantic proximity Read ↗

Gamma-irradiated peripheral blood mononuclear cells can express LAK activity.Semantic proximity Read ↗

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.Semantic proximity Read ↗

Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.Semantic proximity Read ↗

Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.Semantic proximity Read ↗

Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.